Medtronic Pre-Tax Profit Margin 2010-2024 | MDT
Current and historical pre-tax profit margin for Medtronic (MDT) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Medtronic pre-tax profit margin for the three months ending January 31, 2024 was .
| Medtronic Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-01-31 | $32.32B | $5.53B | 17.11% |
| 2023-10-31 | $31.96B | $5.43B | 17.00% |
| 2023-07-31 | $31.56B | $5.52B | 17.48% |
| 2023-04-30 | $31.23B | $5.36B | 17.18% |
| 2023-01-31 | $30.77B | $5.42B | 17.60% |
| 2022-10-31 | $30.81B | $5.63B | 18.27% |
| 2022-07-31 | $31.07B | $5.73B | 18.44% |
| 2022-04-30 | $31.69B | $5.52B | 17.41% |
| 2022-01-31 | $31.79B | $5.48B | 17.24% |
| 2021-10-31 | $31.80B | $5.11B | 16.08% |
| 2021-07-31 | $31.60B | $4.14B | 13.12% |
| 2021-04-30 | $30.12B | $3.90B | 12.93% |
| 2021-01-31 | $27.93B | $2.53B | 9.07% |
| 2020-10-31 | $27.87B | $2.89B | 10.38% |
| 2020-07-31 | $27.93B | $3.66B | 13.11% |
| 2020-04-30 | $28.91B | $4.06B | 14.02% |
| 2020-01-31 | $31.06B | $5.14B | 16.55% |
| 2019-10-31 | $30.89B | $4.93B | 15.97% |
| 2019-07-31 | $30.67B | $4.99B | 16.29% |
| 2019-04-30 | $30.56B | $5.20B | 17.01% |
| 2019-01-31 | $30.56B | $5.63B | 18.43% |
| 2018-10-31 | $30.38B | $5.29B | 17.40% |
| 2018-07-31 | $29.95B | $5.66B | 18.90% |
| 2018-04-30 | $29.95B | $5.68B | 18.95% |
| 2018-01-31 | $29.73B | $5.39B | 18.12% |
| 2017-10-31 | $29.64B | $5.33B | 17.97% |
| 2017-07-31 | $29.93B | $4.81B | 16.07% |
| 2017-04-30 | $29.71B | $4.60B | 15.49% |
| 2017-01-31 | $29.36B | $4.30B | 14.65% |
| 2016-10-31 | $29.01B | $4.51B | 15.56% |
| 2016-07-31 | $28.73B | $4.38B | 15.26% |
| 2016-04-30 | $28.83B | $4.34B | 15.04% |
| 2016-01-31 | $28.57B | $3.39B | 11.86% |
| 2015-10-31 | $25.95B | $3.40B | 13.12% |
| 2015-07-31 | $23.26B | $3.34B | 14.37% |
| 2015-04-30 | $20.26B | $3.49B | 17.21% |
| 2015-01-31 | $17.52B | $3.78B | 21.57% |
| 2014-10-31 | $17.37B | $3.54B | 20.39% |
| 2014-07-31 | $17.20B | $3.64B | 21.14% |
| 2014-04-30 | $17.01B | $3.71B | 21.79% |
| 2014-01-31 | $16.90B | $4.38B | 25.91% |
| 2013-10-31 | $16.76B | $4.58B | 27.31% |
| 2013-07-31 | $16.67B | $4.32B | 25.90% |
| 2013-04-30 | $16.59B | $4.25B | 25.62% |
| 2013-01-31 | $16.43B | $4.13B | 25.13% |
| 2012-10-31 | $16.32B | $4.03B | 24.67% |
| 2012-07-31 | $16.25B | $4.22B | 25.94% |
| 2012-04-30 | $16.18B | $4.15B | 25.61% |
| 2012-01-31 | $15.86B | $3.99B | 25.15% |
| 2011-10-31 | $15.80B | $3.93B | 24.89% |
| 2011-07-31 | $15.68B | $3.64B | 23.23% |
| 2011-04-30 | $15.51B | $3.66B | 23.63% |
| 2011-01-31 | $15.30B | $4.00B | 26.13% |
| 2010-10-31 | $15.30B | $4.07B | 26.57% |
| 2010-07-31 | $15.23B | $4.42B | 29.04% |
| 2010-04-30 | $15.39B | $3.94B | 25.62% |
| 2010-01-31 | $15.45B | $2.74B | 17.75% |
| 2009-10-31 | $15.09B | $2.57B | 17.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $105.150B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
| Stryker (SYK) | United States | $124.585B | 30.89 |
| Boston Scientific (BSX) | United States | $98.912B | 32.89 |
| EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
| ResMed (RMD) | United States | $26.124B | 26.12 |
| Terumo (TRUMY) | Japan | $24.607B | 34.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
| Baxter (BAX) | United States | $20.135B | 14.69 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.535B | 60.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
| Demant (WILYY) | Denmark | $9.782B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
| BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
| Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
| Haemonetics (HAE) | United States | $4.239B | 21.68 |
| Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
| GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
| Envista Holdings (NVST) | United States | $3.394B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
| Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
| Neogen (NEOG) | United States | $2.584B | 24.85 |
| QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
| ICU Medical (ICUI) | United States | $2.361B | 17.62 |
| TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
| Owens & Minor (OMI) | United States | $1.843B | 17.69 |
| Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
| InMode (INMD) | Israel | $1.456B | 7.54 |
| LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
| AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
| Warby Parker (WRBY) | United States | $1.169B | 0.00 |
| AtriCure (ATRC) | United States | $1.131B | 0.00 |
| MacroGenics (MGNX) | United States | $1.005B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
| Evolus (EOLS) | United States | $0.670B | 0.00 |
| Jin Medical (ZJYL) | China | $0.617B | 0.00 |
| Quanterix (QTRX) | United States | $0.604B | 0.00 |
| Valneva SE (VALN) | France | $0.565B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
| TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
| PetIQ (PETQ) | United States | $0.472B | 17.61 |
| ZimVie (ZIMV) | United States | $0.427B | 26.13 |
| Biote (BTMD) | United States | $0.405B | 3.86 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Surmodics (SRDX) | United States | $0.376B | 40.60 |
| Zynex (ZYXI) | United States | $0.368B | 42.41 |
| Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| InterCure (INCR) | Israel | $0.118B | 19.92 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.104B | 0.00 |
| Safety Shot (SHOT) | United States | $0.099B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |